Insider Transactions in Q4 2024 at Teva Pharmaceutical Industries LTD (TEVA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2024
|
Christine Fox EVP, Head of U.S. Commercial |
SELL
Open market or private sale
|
Direct |
19,388
-30.54%
|
$310,208
$16.87 P/Share
|
|
Nov 20
2024
|
Christine Fox EVP, Head of U.S. Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
63,492
+50.0%
|
-
|